CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023
Operating expenses:
Research and development		$ 29,801	$ 59,504
Selling, general and administrative		28,809	12,925
Total operating expenses		58,610	72,429
Loss from operations		(58,610)	(72,429)
Other income:
Other income		289	93
Interest income		8,553	2,189
Total other income, net		8,842	2,282
Net loss before income taxes		(49,768)	(70,147)
Income tax expense (benefit)		1	(179)
Net loss		(49,769)	(69,968)	[1]
Other comprehensive income (loss):
Unrealized gain on marketable securities		190	6	[1]
Comprehensive loss		$ (49,579)	$ (69,962)
Net loss per share attributable to common stockholders-basic		$ (2.34)	$ (35.71)
Net loss per share attributable to common stockholders-diluted		$ (2.34)	$ (35.71)
Weighted-average Class A common shares outstanding, basic (in shares)	[2]	21,281,038	1,959,091
Weighted-average Class A common shares outstanding, diluted (in shares)	[2]	21,281,038	1,959,091

[1] Retroactively recast for the reverse recapitalization as described in Note 3.

[2] Retroactively recast for the reverse recapitalization as described in Note 3. See Note 2 for further information on weighted-average common shares outstanding.